mRNA vaccine trafficking and resulting protein expression after intramuscular administration
Open Access
- 24 November 2023
- journal article
- research article
- Published by Elsevier in Molecular Therapy Nucleic Acids
- Vol. 35 (1) , 102083
Abstract
No abstract availableKeywords
Funding Information
- Moderna
This publication has 29 references indexed in Scilit:
- Mechanism of action of mRNA-based vaccinesExpert Review of Vaccines, 2017
- Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza VirusesMolecular Therapy, 2017
- Characterizing exogenous mRNA delivery, trafficking, cytoplasmic release and RNA–protein correlations at the level of single cellsNucleic Acids Research, 2017
- Local innate immune responses in the vaccine adjuvant‐injected muscleClinical & Translational Immunology, 2016
- Much More than M1 and M2 Macrophages, There are also CD169+ and TCR+ MacrophagesFrontiers in Immunology, 2015
- The contribution of non-human primate models to the development of human vaccines.2014
- Biodegradable Lipids Enabling Rapidly Eliminated Lipid Nanoparticles for Systemic Delivery of RNAi TherapeuticsMolecular Therapy, 2013
- Enhanced Histopathology of the Lymph NodesToxicologic Pathology, 2006
- Distribution of DNA Vaccines Determines Their Immunogenicity After Intramuscular Injection in MiceThe Journal of Immunology, 2000
- Attenuation of green fluorescent protein half-life in mammalian cellsProtein Engineering, Design and Selection, 1999